Vulvar cancer: Epidemiology, clinical presentation, and management options

International Journal of Women's Health

Volumn 7, Issue , 2015, Pages 305-313

  Alkatout, Ibrahim ^a   Schubert, Melanie ^a   Garbrecht, Nele ^a   Weigel, Marion Tina ^a   Jonat, Walter ^a   Mundhenke, Christoph ^a   Günther, Veronika ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Groin dissection; HPV infection; Overall survival; Radical vulvectomy; Sentinel lymph node biopsy; Vulvar cancer

Indexed keywords

CISPLATIN; ERLOTINIB; FLUOROURACIL; GEFITINIB; MITOMYCIN; NAVELBINE; PACLITAXEL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL FEATURE; DYSURIA; EXCISION; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; PATHOLOGICAL ANATOMY; PRIMARY TUMOR; SENTINEL LYMPH NODE BIOPSY; TREATMENT PLANNING; VAGINA BLEEDING; VAGINA CANCER; VAGINA DISCHARGE; VAGINA PAIN; VULVECTOMY;

EID: 84930665326     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S68979     Document Type: Article

References (69)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
2. Hunter DJ. Carcinoma of the vulva: a review of 361 patients. Gynecol Oncol. 1975;3(2):117–123.
3. Gunther V, Alkatout I, Lez C, et al. Malignant melanoma of the urethra: a rare histologic subdivision of vulvar cancer with a poor prognosis. Case Rep Obstet Gynecol. 2012;2012:385175.
4. Way S. The anatomy of the lymphatic drainage of the vulva and its influence on the radical operation for carcinoma. Ann R Coll Surg Engl. 1948;3(4):187–209.
5. Horn LC, Klostermann K, Hautmann S, Höhn AK, Beckmann MW, Mehlhorn G. HPV-assoziierte Veränderungen an Vulva und Vagina [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology]. Pathologe. 2011;32(6):467–475. German.
6. Ngan HY, Tsao SW, Liu SS, Stanley M. Abnormal expression and mutation of p53 in cervical cancer–a study at protein, RNA and DNA levels. Genitourin Med. 1997;73(1):54–58.
7. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol. 1997;90(3):448–452.
8. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997;80(3):505–513.
9. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48(1):6–29.
10. Crum CP. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet Gynecol. 1992;79(3):448–454.
11. Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol. 2007;110(2 Pt 1):296–301.
12. Scurry J. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer. 1999;9(2):89–97.
13. Jach R, Dyduch G, Radon-Pokracka M, et al. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and compari­son of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer. Neuro Endocrinol Lett. 2013;32(4):530–539.
14. Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997;89(20):1516–1523.
15. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithe­lial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50(11):807–810.
16. Medeiros F., Nascimento AF, Crum CP. Early vulvar squamous neo­plasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol. 2005;12(1):20–26.
17. Maclean AB. Vulval cancer: prevention and screening. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):379–395.
18. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45(5):851–856.
19. Trimble EL, Lewis JL Jr, Williams LL, et al. Management of vulvar melanoma. Gynecol Oncol. 1992;45(3):254–258.
20. Copeland LJ, Sneige N, Gershenson DM, McGuffee VB, Abdul-Karim F, Rutledge FN. Bartholin gland carcinoma. Obstet Gynecol. 1986;67(6):794–801.
21. Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180(1 Pt 1):24–27.
22. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104.
23. Al-Najar A, Alkatout I, Al-Sanabani S, et al. External validation of the proposed T and N categories of squamous cell carcinoma of the penis. Int J Urol. 2011;18(4):312–316.
24. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer. 2000;89(1):116–122.
25. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57(3):327–334.
26. Alkatout I, Naumann CM, Hedderich J, et al. Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination. Urol Oncol. 2010;29(6):774–781.
27. Sohaib SA, Richards PS, Ind T, et al. MR imaging of carcinoma of the vulva. AJR Am J Roentgenol. 2002;178(2):373–377.
28. Gunther V, Malchow B, Schubert M, et al. Impact of radical operative treatment on the quality of life in women with vulvar cancer–a retro­spective study. Eur J Surg Oncol. 2014;40(7):875–882.
29. Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58(5):574–579.
30. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113(4):895–901.
31. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–314.
32. De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95(11):2331–2338.
33. Gonzalez Bosquet J, Magrina JF, Magtibay PM, et al. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gynecol Oncol. 2007;105(3):742–746.
34. Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemo­ral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg. 2003;196(3):442–450.
35. Weikel W, Hoffman M, Steiner E, Knapstein PG, Koelbl H. Reconstruc­tive surgery following resection of primary vulvar cancers. Gynecol Oncol. 2005;99(1):92–100.
36. Landoni F, Proserpio M, Manoe A, Cormio G, Zanetta G, Milani R. Repair of the perineal defect after radical vulvar surgery: direct closure versus skin flaps reconstruction. A retrospective comparative study. Aust N Z J Obstet Gynaecol. 1995;35(3):300–304.
37. Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospec­tive study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79(4):490–497.
38. Klemm P, Marnitz S, Köhler C, Braig U, Schneider A. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol Oncol. 2005;99(1):101–105.
39. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991;164(4):997–1003; discussion 1003–1004.
40. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128(2):155–159.
41. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol. 1983;16(2):179–189.
42. de Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node proce­dure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 2000;18(15):2811–2816.
43. Van der Zee AG, Oonk MH, de Hullu AJ, et al. Sentinel node dissec­tion is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–889.
44. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4–16.
45. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006; 98(9):599–609.
46. Levenback CF, van der Zee AG, Rob L, et al. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009;114(2):151–156.
47. Oonk MH, van de Nieuwenhof HP, van der Zee AG, de Hullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev Anticancer Ther. 2009;10(1):61–69.
48. Selman TJ, Luesley DM, Acheson N, Khan KS, Mann CH. A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol. 2005;99(1):206–214.
49. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11(7):646–652.
50. Hassanzade M, Attaran M, Treglia G, Yousefi Z, Sadeghi R. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013;130(1):237–245.
51. Boran N, Kayikcioglu F, Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol. 2003;90(2):492–493.
52. Fons G, ter Rahe B, Sloof G, de Hullu AJ, van der Velden J. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol. 2004;92(3):981–984.
53. Decesare SL, Fiorica JV, Roberts WS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol. 1997;66(3):425–428.
54. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30(31):3786–3791.
55. Shylasree TS, Bryant A, Howells RE. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev. 2011;(4): CD003752.
56. Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79–85.
57. Martinez-Palones JM, Pérez-Benavente MA, Gil-Moreno A, et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol. 2006;103(3):865–870.
58. Tropé C, Johnsson JE, Larsson G, Simonsen E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep. 1980;64(4–5):639–642.
59. Deppe G, Bruckner HW, Cohen CJ. Adriamycin treatment of advanced vulvar carcinoma. Obstet Gynecol. 1977;50(1 Suppl):13s–14s.
60. Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 2006;18(12):2089–2097.
61. Fukutome M, Maebayashi K, Nasu S, Seki K, Mitsuhashi N. Enhance­ment of radiosensitivity by dual inhibition of the HER family with ZD1839 (“Iressa”) and trastuzumab (“Herceptin”). Int J Radiat Oncol Biol Phys. 2006;66(2):528–536.
62. Hacker NF, Berek JS, Juillard GJ, Lagasse LD. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer. 1984;54(10):2056–2061.
63. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68(6):733–740.
64. Barnes EA, Thomas G. Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol. 2006;16(3):168–176.
65. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol. 2006;60(3):227–241.
66. Woolderink JM, de Bock GH, de Hullu JA, et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103(1):293–299.
67. Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemo­radiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer. 1996;77(8):1472–1478.
68. Schünke M, Schulte E, Schumacher U. Prometheus LernAtlas der Anatomie: Allgemenie Anatomie und Bewe gungssytem. [Prometheus learning Atlas of Anatomy: General Anatomy and Movement System]. 1st Ed. Thieme. Stuttgart, Germany; 2006. German.
69. Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the Vulva. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7–27.